We recently compiled a list of the 8 Unstoppable Stocks That Could Make You Richer. In this article, we are going to take a ...

Keytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In India, its high cost limits access. With patents expiring soon, ...

They conducted scientific research while on the ISS, where astronauts Sunni Williams and Butch Wilmore remain until their newly scheduled return in February. Williams and Wilmore initially were ...

The next day, an ISS-bound SpaceX cargo ship is scheduled for launch from the Kennedy Space Center. After an automated rendezvous, the ship will dock at the just vacated forward port on Nov. 5 ...

Troubleshooting the leaking ISS is ongoing, with NASA and Russia now identifying 50 "areas of concern" and four cracks, according to a media report. NASA and its Russian counterpart have ...

A NASA astronaut who just returned from the International Space Station has been hospitalized for an unspecified medical condition but remains stable, the US space agency said Friday. The four ...

SpaceX maintains a fleet of reusable spacecraft and has flown to the ISS 44 times. The Elon Musk-owned company remains the only US option for Nasa astronaut trips to and from the ISS. Boeing’s ...

Marking 235 days in space, the Crew-8 astronauts' stay aboard the ISS, a football field-sized science lab 250 miles in orbit, was longer than the typical six-month astronaut missions on the station.

After living and working on the International Space Station (ISS) for more than 200 days, NASA astronauts Matthew Dominick, Michael Barratt, and Jeanette Epps, and Roscosmos cosmonaut Alexander ...

Their 235 days in space made it longer than the usual six-month ISS mission duration and marked the longest stay in orbit for SpaceX's reusable Crew Dragon spacecraft. NASA initially said the ...

With these approvals, KEYTRUDA is now authorized for 30 indications in the EU, including five in gynecologic cancers, Merck said in a statement. RAHWAY: Merck, also known as MSD outside the US and ...

Merck's diversified pipeline includes promising oncology candidates and a new pneumococcal vaccine, but lacks a ready-made Keytruda replacement. Investors should monitor R&D updates closely ...